Journal of Molecular Medicine

, Volume 90, Issue 12, pp 1497–1504 | Cite as

Primary hyperoxaluria type III—a model for studying perturbations in glyoxylate metabolism

  • Ruth BelostotskyEmail author
  • James Jonathon Pitt
  • Yaacov Frishberg
Original Article


Perturbations in glyoxylate metabolism lead to the accumulation of oxalate and give rise to primary hyperoxalurias, recessive disorders characterized by kidney stone disease. Loss-of-function mutations in HOGA1 (formerly DHDPSL) are responsible for primary hyperoxaluria type III. HOGA1 is a mitochondrial 4-hydroxy-2-oxoglutarate aldolase catalyzing the fourth step in the hydroxyproline pathway. We investigated hydroxyproline metabolites in the urine of patients with primary hyperoxaluria type III using gas chromatography–mass spectroscopy. Significant increases in concentrations of 4-hydroxy-2-oxoglutarate and its precursor and derivative 4-hydroxyglutamate and 2,4-dihydroxyglutarate, respectively, were found in all patients as compared to carriers of the corresponding mutations or healthy controls. Despite a functional block in the conversion of hydroxyproline to glyoxylate—the immediate precursor of oxalate—the production of oxalate increases. To explain this apparent contradiction, we propose a model of glyoxylate compartmentalization in which cellular glyoxylate is normally prevented from contact with the cytosol where it can be oxidized to oxalate. We propose that HOGA1 deficiency results in the accumulation of 4-hydroxy-2-oxoglutarate in the mitochondria and its transport into the cytosol where it is converted to glyoxylate by a different cytosolic aldolase. In human hepatocyte cell lines, we detected a cytosolic 4-hydroxy-2-oxoglutarate aldolase activity not due to HOGA1. These studies provide a diagnostic tool for primary hyperoxaluria type III and shed light on glyoxylate metabolism and the pathogenesis of primary hyperoxalurias.


HOGA1 PHIII Hydroxyproline pathway Glyoxylate Oxalate DHDPSL 



The authors are indebted to Prof. Hanna Mandel for helpful advice. Sections of this work were supported by the Victorian Government's Operational Infrastructure Support Program.

Conflict of interest

The authors declare that no conflict of interest exists.

Supplementary material

109_2012_930_MOESM1_ESM.pdf (58 kb)
ESM 1 (PDF 58 kb)


  1. 1.
    Belostotsky R, Seboun E, Idelson GH, Milliner DS, Becker-Cohen R, Rinat C, Monico CG, Feinstein S, Ben-Shalom E, Magen D et al (2010) Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet 87:392–399PubMedCrossRefGoogle Scholar
  2. 2.
    Monico CG, Rossetti S, Belostotsky R, Cogal AG, Herges RM, Seide BM, Olson JB, Bergstrahl EJ, Williams HJ, Haley WE et al (2011) Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol 6:2289–2295PubMedCrossRefGoogle Scholar
  3. 3.
    Riedel TJ, Johnson LC, Knight J, Hantgan RR, Holmes RP, Lowther WT (2011) Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria. PLoS One 6:e26021PubMedCrossRefGoogle Scholar
  4. 4.
    Williams EL, Bockenhauer D, Van't Hoff WG, Johri N, Laing C, Sinha MD, Unwin R, Viljoen A, Rumsby G (2012) The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3. Nephrol Dial Transplant (in press)Google Scholar
  5. 5.
    Baker PR, Cramer SD, Kennedy M, Assimos DG, Holmes RP (2004) Glycolate and glyoxylate metabolism in HepG2 cells. Am J Physiol Cell Physiol 287:C1359–C1365PubMedCrossRefGoogle Scholar
  6. 6.
    Coulter-Mackie MB (2006) 4-Hydroxyproline metabolism and glyoxylate production: a target for substrate depletion in primary hyperoxaluria? Kidney Int 70:1891–1893PubMedCrossRefGoogle Scholar
  7. 7.
    Dijcker JC, Plantinga EA, van Baal J, Hendriks WH (2011) Influence of nutrition on feline calcium oxalate urolithiasis with emphasis on endogenous oxalate synthesis. Nutr Res Rev 22:1–15Google Scholar
  8. 8.
    Mdluli K, Booth MP, Brady RL, Rumsby G (2005) A preliminary account of the properties of recombinant human glyoxylate reductase (GRHPR), LDHA and LDHB with glyoxylate, and their potential roles in its metabolism. Biochim Biophys Acta 1753:209–216PubMedCrossRefGoogle Scholar
  9. 9.
    Knight J, Jiang J, Assimos DG, Holmes RP (2006) Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int 70:1929–1934PubMedCrossRefGoogle Scholar
  10. 10.
    Behnam JT, Williams EL, Brink S, Rumsby G, Danpure CJ (2006) Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells. Biochem J 394:409–416PubMedCrossRefGoogle Scholar
  11. 11.
    Yoshida Y, Holloway GP, Ljubicic V, Hatta H, Spriet LL, Hood DA, Bonen A (2007) Negligible direct lactate oxidation in subsarcolemmal and intermyofibrillar mitochondria obtained from red and white rat skeletal muscle. J Physiol 582:1317–1335PubMedCrossRefGoogle Scholar
  12. 12.
    Holmes RS, Goldberg E (2009) Computational analyses of mammalian lactate dehydrogenases human, mouse, opossum and platypus LDHs. Comput Biol Chem 33:379–385PubMedCrossRefGoogle Scholar
  13. 13.
    Samland AK, Sprenger GA (2006) Microbial aldolases as C–C bonding enzymes unknown treasures and new developments. Appl Microbiol Biotechnol 71:253–264PubMedCrossRefGoogle Scholar
  14. 14.
    Machajewski TD, Wong CH (2000) The catalytic asymmetric aldol reaction. Angew Chem Int Ed Engl 39:1352–1375PubMedCrossRefGoogle Scholar
  15. 15.
    Anderson M, Scholtz JM, Schuster SM (1985) Rat liver 4-hydroxy-2-ketoglutarate aldolase: purification and kinetic characterization. Arch Biochem Biophys 236:82–97PubMedCrossRefGoogle Scholar
  16. 16.
    Kobes RD, Dekker EE (1969) 2-Keto-4-hydroxyglutarate aldolase of bovine liver. Purification, criteria of purity, and general properties. J Biol Chem 244:1919–1925PubMedGoogle Scholar
  17. 17.
    McLean A, Marwick MJ, Clayton BE (1973) Enzymes involved in phenylalanine metabolism in the human foetus and child. J Clin Pathol 26:678–683PubMedCrossRefGoogle Scholar
  18. 18.
    Alaux S, Kusk M, Sagot E, Bolte J, Jensen AA, Bräuner-Osborne H, Gefflaut T, Bunch L (2005) Chemoenzymatic synthesis of a series of 4-substituted glutamate analogues and pharmacological characterization at human glutamate transporters subtypes 1-3. J Med Chem 48:7980–7992PubMedCrossRefGoogle Scholar
  19. 19.
    Maitra U, Dekker EE (1963) Enzymatic steps in the conversion of gamma-hydroxyglutamate to glyoxylate and alanine. J Biol Chem 238:3660–3669PubMedGoogle Scholar
  20. 20.
    Birdsey GM, Lewin J, Holbrook JD, Simpson VR, Cunningham AA, Danpure CJ (2005) A comparative analysis of the evolutionary relationship between diet and enzyme targeting in bats, marsupials and other mammals. Proc Biol Sci 272:833–840PubMedCrossRefGoogle Scholar
  21. 21.
    Danpure CJ, Fryer P, Jennings PR, Allsop J, Griffiths S, Cunningham A (1994) Evolution of alanine:glyoxylate aminotransferase 1 peroxisomal and mitochondrial targeting. A survey of its subcellular distribution in the livers of various representatives of the classes Mammalia, Aves and Amphibia. Eur J Cell Biol 64:295–313PubMedGoogle Scholar
  22. 22.
    Danpure CJ (1993) Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase. Biochimie 75:309–315PubMedCrossRefGoogle Scholar
  23. 23.
    Coulter-Mackie MB, Lian Q, Wong SG (2005) Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor. Protein Expr Purif 41:18–26PubMedCrossRefGoogle Scholar
  24. 24.
    Hopper ED, Pittman AM, Fitzgerald MC, Tucker CL (2008) In vivo and in vitro examination of stability of primary hyperoxaluria-associated human alanine:glyoxylate aminotransferase. J Biol Chem 283:30493–30502PubMedCrossRefGoogle Scholar
  25. 25.
    Caldwell EF, Mayor LR, Thomas MG, Danpure CJ (2004) Diet and the frequency of the alanine:glyoxylate aminotransferase Pro11Leu polymorphism in different human populations. Hum Genet 115:504–509PubMedCrossRefGoogle Scholar
  26. 26.
    Knight J, Easter LH, Neiberg R, Assimos DG, Holmes RP (2009) Increased protein intake on controlled oxalate diets does not increase urinary oxalate excretion. Urol Res 37:63–68PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Ruth Belostotsky
    • 1
    Email author
  • James Jonathon Pitt
    • 2
  • Yaacov Frishberg
    • 1
    • 3
  1. 1.Division of Pediatric NephrologyShaare Zedek Medical CenterJerusalemIsrael
  2. 2.VCGS Pathology, Murdoch Childrens Research InstituteRoyal Children’s HospitalParkvilleAustralia
  3. 3.Hadassah-Hebrew University School of MedicineJerusalemIsrael

Personalised recommendations